News
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing September 21, 2021 11:50 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, through an extensive, established European Union distribution network, ...
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet   CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European Union distribution network, today announced that the Company has entered into a debt exchange agreement with its senior lender (Lender) to further reduce the Company’s debt. Under the ...
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021   CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, today provided a business update and reported financial results for the second quarter ended June 30, 2021. Greg Siokas, Chief Executive Officer of Cosmos Holdings, stated, "I am pleased to report ...
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users Company Partners with Leading China E-Commerce Solutions Provider REMAI to Launch Sky Premium Life Products on Tmall Global   CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded pharmaceuticals, nutraceuticals and OTC medications, today announced that it has signed a distribution agreement for its full line of proprietary nutraceuticals, Sky Premium Life, ...
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share   CEO has converted $4.0 million of the Company’s debt to date; the conversion price represents a premium to market CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo